Refractory Erdheim-Chester disease
| Drug | Drug Name | Drug Description |
|---|---|---|
| DB08881 | Vemurafenib | A kinase inhibitor used to treat patients with Erdheim-Chester Disease who have the BRAF V600 mutation, and melanoma in patients who have the BRAF V600E mutation. |
| Drug | Drug Name | Phase | Status | Count |
|---|